ClassID:

96784

C07K14/07 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; DNA viruses; Poxviridae, e.g. avipoxvirus Vaccinia virus; Variola virus

Recent Application in this class:
#1
20260115300
2026-04-30

GLYCOTARGETING THERAPEUTICS

#2
20240067936
2024-02-29

ONCOLYTIC VIRUS AND USES THEREOF

#3
20240016865
2024-01-18

Oncolytic viruses targeting STAT3

#4
20220133825
2022-05-05

ONCOLYTIC VIRUSES TARGETING STAT3

#5
20220133824
2022-05-05

ONCOLYTIC VIRUSES TARGETING STAT3

#6
20210363543
2021-11-25

Self Replicating RNA System

#7
20210230230
2021-07-29

Soluble Forms of Hendra and Nipah Virus G Glycoprotein

#8
20200362313
2020-11-19

METHOD OF ENHANCING RNA EXPRESSION IN A CELL

#9
20200129629
2020-04-30

Glycotargeting therapeutics

#10
20190142883
2019-05-16

Oncolytic viruses targeting STAT3

#11
20190031719
2019-01-31

Soluble Forms of Hendra and Nipah Virus G Glycoprotein

#12
20170174728
2017-06-22

Soluble forms of Hendra and Nipah virus G glycoprotein

#13
20160250320
2016-09-01

Immunoregulatory peptides and methods of use

#14
20150306208
2015-10-29

Soluble forms of hendra and nipah virus G glycoprotein

#15
20140120064
2014-05-01

Generation of new pancreatic beta cells

#16
20130210741
2013-08-15

Immunoregulatory peptides and methods of use

#17
20130203683
2013-08-08

Immunoregulatory peptides and methods of use

#18
20130203679
2013-08-08

Immunoregulatory peptides and methods of use

#19
20130171132
2013-07-04

Soluble forms of Hendra and Nipah virus G glycoprotein

#20
20130171131
2013-07-04

Soluble forms of hendra and nipah virus G glycoprotein

#21
20100317564
2010-12-16

Immunoregulatory peptides and methods of use

#22
20090041772
2009-02-12

Soluble forms of Hendra and Nipah virus G glycoprotein

#23
20070237790
2007-10-11

Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes